These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1608896)

  • 1. Analytical control procedures of immunoreactivity for IgG and Fab fragments specific to haptens.
    Cano NJ; Sabouraud AE; Urtizberea M; Carcagne J; Grandgeorge M; Scherrmann JM
    Pharm Res; 1992 May; 9(5):643-7. PubMed ID: 1608896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopharmacological activity of monoclonal antidigitoxin.
    Urtizberea M; Latour M; Edelman L; Carcagne J; Armand J; Scherrmann JM
    Dev Biol Stand; 1990; 71():147-57. PubMed ID: 2401380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon.
    Smith TW; Lloyd BL; Spicer N; Haber E
    Clin Exp Immunol; 1979 Jun; 36(3):384-96. PubMed ID: 114346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a sensitive radioimmunoassay for Fab fragments: application to Fab pharmacokinetics in humans.
    Thanh-Barthet CV; Urtizberea M; Sabouraud AE; Cano NJ; Scherrmann JM
    Pharm Res; 1993 May; 10(5):692-6. PubMed ID: 8321833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and specificity of the anti-digoxin antibody 40-50.
    Jeffrey PD; Schildbach JF; Chang CY; Kussie PH; Margolies MN; Sheriff S
    J Mol Biol; 1995 Apr; 248(2):344-60. PubMed ID: 7739045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of digoxin-specific F(ab')2-antibody fragments in the treatment of digitoxin poisoning: experimental investigations in the cat.
    Hess T; Scholtysik G; Riesen W
    Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):93-7. PubMed ID: 6780367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.
    Ochs HR; Smith TW
    J Clin Invest; 1977 Dec; 60(6):1303-13. PubMed ID: 914999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting rates of reversal of digoxin toxicity by digoxin-specific IgG and Fab fragments.
    Lloyd BL; Smith TW
    Circulation; 1978 Aug; 58(2):280-3. PubMed ID: 668076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity and dose-dependent digoxin Na+K+ATPase dissociation by monoclonal digoxin-specific antibodies.
    Cano NJ; Navarro-Teulon I; Debray M; Piechaczyk M; Scherrmann JM
    Biochem Pharmacol; 1995 Nov; 50(11):1867-72. PubMed ID: 8615866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison by 1H NMR of the hapten environment in the combining site of the dinitrophenyl binding IgA protein 315 and its fragments.
    Morris AT; Givol D; Dwek RA
    Immunochemistry; 1978 Aug; 15(8):519-22. PubMed ID: 730222
    [No Abstract]   [Full Text] [Related]  

  • 11. Chromatographic analysis of the hydrophobic interactions of rabbit IgG immunoglobulins and their papain-digested fragments by bis-(p-chlorophenyl)-acetic acid coupled to aminohexyl sepharose.
    Furuya K; Urasawa S
    Mol Immunol; 1982 May; 19(5):705-17. PubMed ID: 7110142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent reversal of acute murine colchicine poisoning by goat colchicine-specific Fab fragments.
    Sabouraud A; Urtizberea M; Grandgeorge M; Gattel P; Makula ME; Scherrmann JM
    Toxicology; 1991; 68(2):121-32. PubMed ID: 1891780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of rabbit IgG and its enzymatically derived fragments to homologous peritoneal macrophages.
    Ganczakowski M; Leslie RG
    Immunology; 1979 Mar; 36(3):487-94. PubMed ID: 437840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dependence of the specific activity of antitetanus immunoglobulin on the degree of its fragmentation].
    Gavrilenkova VIu; Selezneva VP; Runova VF; Kargina TM
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):68-71. PubMed ID: 2939668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fab antibody fragments: some applications in clinical toxicology.
    Flanagan RJ; Jones AL
    Drug Saf; 2004; 27(14):1115-33. PubMed ID: 15554746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further characterization of the alternative protein-A interaction of immunoglobulins: demonstration of an Fc-binding fragment of protein A expressing the alternative reactivity.
    Inganäs M; Johansson SG; Sjöquist J
    Scand J Immunol; 1981 Oct; 14(4):379-88. PubMed ID: 7038851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-chromatographic method for the purification of a bivalently active monoclonal IgG antibody from biological fluids.
    Bilgiçer B; Thomas SW; Shaw BF; Kaufman GK; Krishnamurthy VM; Estroff LA; Yang J; Whitesides GM
    J Am Chem Soc; 2009 Jul; 131(26):9361-7. PubMed ID: 19534466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.
    Buchegger F; Haskell CM; Schreyer M; Scazziga BR; Randin S; Carrel S; Mach JP
    J Exp Med; 1983 Aug; 158(2):413-27. PubMed ID: 6886623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of cardiodigin, endogenous inhibitor of Na+,K+-ATPase, with antidigoxin and antidigitoxin antibodies.
    Fagoo M; Godfraind T
    Biochem Biophys Res Commun; 1985 Jun; 129(2):553-9. PubMed ID: 2990458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity.
    Jeffrey PD; Strong RK; Sieker LC; Chang CY; Campbell RL; Petsko GA; Haber E; Margolies MN; Sheriff S
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10310-4. PubMed ID: 8234291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.